通过细胞MC5R信号拦截补体放大循环,可以改善膜性病
Jing Liu1, Mingzhuo Zhang1, Yan Ge1
1Division of Nephrology, Department of Medicine, University of Toledo College of Medicine, Toledo, OH, USA.
概括
黑色皮质激素治疗,特别是针对皮质细胞中的黑色皮质激素5受体 (MC5R),通过抑制补体激活,显示出治疗膜性病的前景.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 药理学 药理学 是一个学科.
背景情况:
- 膜性病 (MN) 是成年人性综合征的主要原因.
- 目前对MN的治疗有局限性,潜在的机制需要进一步阐明.
- 梅拉诺科林治疗显示了MN的潜力,但其确切的作用和目标尚不清楚.
研究的目的:
- 在THSD7A相关的膜性脏病的小鼠模型中研究黑色皮质素剂的治疗潜力和机制.
- 确定在MN病原和治疗的背景下,细胞中黑色皮质素5受体 (MC5R) 的作用.
主要方法:
- 使用了一种与THSD7A相关的膜性脏病的异质小鼠模型.
- 施用了各种黑色皮质激素剂,包括储物皮质激素注射,NDP-MSH和PG-901.
- 产生了MC5R淘汰赛小鼠,并进行了podocyte特定的MC5R复制实验.
- 分析了补充元件 (C3,C5b-9) 的球沉积和补充因子B和D的表达.
- 研究了氧酶增殖器激活受体玛 (PPARγ) 信号的参与.
主要成果:
- 在MN小鼠模型中,梅拉诺科林药物减轻了蛋白尿和改善了质细胞病变.
- MC5R淘汰会加剧MN,并消除了黑色皮质素的治疗效果.
- 足细胞MC5R对于黑色皮质蛋白介导的防护对MN的保护至关重要.
- 通过PPARγ-依赖的机制,MC5R激素因子通过抑制补充因子B和D的podocyte表达来减少质C5b-9和C3沉积.
结论:
- 细胞MC5R在膜性病中起着关键的保护作用.
- 通过MC5R,黑色皮质素治疗通过调节补充级联为MN提供了一种新的治疗策略.
- 向细胞中的MC5R可能是治疗膜性病的新途径.
相关概念视频
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...